NewGenIvf Group Limited (NIVF) Stock Analysis & Winston Score
NewGenIvf Group Limited runs fertility clinics that help people have babies through in vitro fertilization, or IVF. The company offers fertility treatments, egg freezing, and related medical services to patients who are struggling to conceive naturally. It operates in Southeast Asia, with clinics in countries like Thailand and Cambodia. The company makes money by charging patients directly for fertility procedures, which can cost thousands of dollars per treatment cycle. NewGenIvf is a small company with a market cap near zero, meaning it is very early-stage and financially fragile — its deeply negative operating margin shows it is spending far more than it earns. The main growth driver is rising demand for fertility services across Asia, where IVF usage is growing quickly, but the biggest risk is that the company may struggle to reach profitability before running out of cash.
Winston Score: 22/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (4/30)
- Growth: Weak (2/20)
- Cash Flow: Data not available (0/10)
- Stability: Good (5/10)
- Valuation: Good (6/10)
- Ownership: Mixed (4/15)
Key Facts
Price: $1.05
Market Cap: $0M
Sector: Healthcare
Industry: Medical - Care Facilities
Exchange: NASDAQ Global Market

